Free circulating DNA based colorectal cancer screening from peripheral blood: The possibility of the methylated septin 9 gene marker;Szabad DNS-alapú vastagbéldaganat-szurés perifériás vérbol: a metilált szeptin-9 génmarker lehetoségei

Orvosi Hetilap

Volumn 150, Issue 21, 2009, Pages 969-977

  Tóth, Kinga ^a,c   Galamb, Orsolya ^a,b   Spisák, Sándor ^a,b   Wichmann, Barnabás ^a   Sipos, Ferenc ^a   Leiszter, Katalin ^a   Molnár, Jeannette ^a   Molnár, Béla ^a,b   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NONE   (Hungary)

Author keywords

Colorectal cancer; Free circulating DNA; Methylation; Peripheral blood; Septin 9

Indexed keywords

DNA; SEPTIN;

ARTICLE; BLOOD; CANCER SCREENING; COLORECTAL CANCER; DNA DETERMINATION; DNA METHYLATION; HUMAN; MARKER GENE;

EID: 66149110301     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28625     Document Type: Article

References (46)

1. Gormally, E., Caboux, E., Vineis, P. és mtsa: Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological signifi cance. Mutat. Res., 2007, 635, 105- 117.
2. Péter Z., Tulassay Zs.: A kolonoszkópia a vatagbélszurés elsod-leges módszere. Orv. Hetil., 2009, 150, 299-304.
3. Calvert, P. M., Frucht, H.: The genetics of colorectal cancer. Ann. Intern. Med., 2002, 137, 603-612.
4. Grady, W. M., Markowitz, S. D.: Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet., 2002, 3, 101-128.
5. Kahlenberg, M. S., Sullivan, J. M., Witmer, D. D. és mtsa: Molecular prognostics in colorectal cancer. Surg. Oncol., 2003, 12, 173-186.
6. Leslie, A., Carey, F. A., Pratt, N. R. és mtsa: The colorectal adenoma-carcinoma sequence. Br. J. Surg., 2002, 89, 845-860.
7. Boni, L., Cassinotti, E., Canziani, M. és mtsai: Free circulating DNA as possible tumour marker in colorectal cancer. Surg. Oncol., 2007, 16, 29-31.
8. Jass, J. R., Walsh, M. D., Barker, M. és mtsai: Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur. J. Cancer, 2002, 38, 858-866.
9. Tong, Y. K., Lo, Y. M.: Diagnostic developments involving cell-free (circulating) nucleic acids. Clin. Chim. Acta., 2006, 363, 187-196.
10. Seligmann, M.: Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid. C. R. Hebd. Seances. Acad. Sci., 1957, 245, 243-245.
11. Steinman, C. R.: Free DNA in serum and plasma from normal adults. J. Clin. Invest., 1975, 56, 512-515.
12. Anker, P., Stroun, M., Maurice, P. A.: Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res., 1975, 35, 2375-2382.
13. Leon, S. A., Shapiro, B., Sklaroff, D. M. és mtsa: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 1977, 37, 646-650.
14. Stroun, M., Anker, P., Lyautey, J. és mtsai: Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 1987, 23, 707-712.
15. Morozkin, E. S., Laktionov, P. P., Rykova, E. Y. és mtsa: Extracellular nucleic acids in cultures of long-term cultivated eukaryotic cells. Ann. N. Y. Acad. Sci., 2004, 1022, 244-249.
16. Vlassov, V. V., Laktionov, P. P., Rykova, E. Y.: Extracellular nucleic acids. Bioessays, 2007, 29, 654-667.
17. Chen, Z., Fadiel, A., Naftolin, F. és mtsai: Circulation DNA: biological implications for cancer metastasis and immunology. Med. Hypotheses, 2005, 65, 956-961.
18. Anker, P., Mulcahy, H., Chen, X. Q. és mtsa: Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev., 1999, 18, 65-73.
19. Siedlecki, P., Zielenkiewicz, P.: Mammalian DNA methyltrans-ferases. Acta Biochim. Pol., 2006, 53, 245-256.
20. Hall, P. A., Russell, S. E.: The pathobiology of the septin gene family. J. Pathol., 2004, 204, 489-505.
21. Kartmann, B., Roth, D.: Novel roles for mammalian septins: from vesicle traffi cking to oncogenesis. J. Cell Sci., 2001, 114, 839-844.
22. Pan, F., Malmberg, R. L., Momany, M.: Analysis of septins across kingdoms reveals orthology and new motifs. BMC Evol. Biol., 2007, 7, 103.
23. McIlhatton, M. A., Burrows, J. F., Donaghy, P. G. és mtsai: Ge-nomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene, 2001, 20, 5930-5939.
24. McDade, S. S., Hall, P. A., Russell, S. E.: Translational control of SEPT9 isoforms is perturbed in disease. Hum. Mol. Genet., 2007, 16, 742-752.
25. Kinoshita, M.: Diversity of septin scaffolds. Curr. Opin. Cell Biol., 2006, 18, 54-60.
26. Tatsumi, K., Taki, T., Taniwaki, M. és mtsai: The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines. Genes Chromosomes Cancer, 2001, 30, 230- 235.
27. Kim, H. J., Ki, C. S., Park, Q. és mtsai: MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature. Genes Chromosomes Cancer, 2003, 38, 8-12.
28. Osaka, M., Rowley, J. D., Zeleznik-Le, N. J.: MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc. Natl. Acad. Sci. USA, 1999, 96, 6428-6433.
29. Taki, T., Ohnishi, H., Shinohara, K. és mtsai: AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res., 1999, 59, 4261- 4265.
30. Kojima, K., Sakai, I., Hasegawa, A. és mtsai: FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia, 2004, 18, 998-1005.
31. Corral, J., Lavenir, I., Impey, H. és mtsai: An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell, 1996, 85, 853-861.
32. Kreuziger, L. M., Porcher, J. C., Ketterling, R. P. és mtsa: An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk. Res., 2007, 31, 1145- 1148.
33. Kuhlenbäumer, G., Hannibal, M. C., Nelis, E. és mtsai: Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat. Genet., 2005, 37, 1044-1046.
34. Sørensen, A. B., Lund, A. H., Ethelberg, S. és mtsai: Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J. Virol., 2000, 74, 2161-2168.
35. Kim, D. S., Hubbard, S. L., Peraud, A. és mtsai: Analysis of mammalian septin expression in human malignant brain tumors. Neoplasia, 2004, 6, 168-178.
36. Tanaka, M., Tanaka, T., Matsuzaki, S. és mtsai: Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers. Med. Sci. Monit., 2003, 9, 61-68.
37. Russell, S. E., McIlhatton, M. A., Burrows, J. F. és mtsai: Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res., 2000, 60, 4729-4734.
38. Kalikin, L. M., Sims, H. L., Petty, E. M.: Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors. Genomics, 2000, 63, 165-172.
39. Burrows, J. F., Chanduloy, S., McIlhatton, M. A. és mtsai: Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J. Pathol., 2003, 201, 581-588.
40. Scott, M., McCluggage, W. G., Hillan, K. J. és mtsai: Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int. J. Cancer, 2006, 118, 1325-1329.
41. Gonzalez, M. E., Peterson, E. A., Privette, L. M. és mtsai: High SEPT9-v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res., 2007, 67, 8554- 8564.
42. Montagna, C., Lyu, M. S., Hunter, K. és mtsai: The Septin 9 (MSF) gene is amplifi ed and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res., 2003, 63, 2179-2187.
43. Ebert, M. P., Model, F., Mooney, S. és mtsai: Aristaless-like homeo-box-4 gene methylation is a potential marker for colorectal ade-nocarcinomas. Gastroenterology, 2006, 131, 1418-1430.
44. Model, F., Osborn, N., Ahlquist, D. és mtsai: Identifi cation and validation of colorectal neoplasia-specifi c methylation markers for accurate classifi cation of disease. Mol. Cancer Res., 2007, 5, 153-163.
45. Lofton-Day, C., Model, F., Devos, T. és mtsai: DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem., 2008, 54, 414-423.
46. Grützmann, R., Molnar, B., Pilarsky, C. és mtsai: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE, 2008, 3, 3759.